Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ) Key Developments | Reuters.com
Edition:
United States

Shenzhen Salubris Pharmaceuticals Co Ltd (002294.SZ)

002294.SZ on Shenzhen Stock Exchange

27.17CNY
29 Jun 2016
Change (% chg)

¥0.39 (+1.46%)
Prev Close
¥26.78
Open
¥26.91
Day's High
¥27.68
Day's Low
¥26.90
Volume
5,206,067
Avg. Vol
3,253,014
52-wk High
¥35.00
52-wk Low
¥21.79

Latest Key Developments (Source: Significant Developments)

Shenzhen Salubris Pharmaceuticals announces 2015 dividend payment date
Monday, 25 Apr 2016 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:To pay cash dividend of 6 yuan per 10 shares (before tax) to shareholders for 2015 as a record of April 29.The company's shares will be traded ex-right and ex-dividend on May 3 and the dividend will be paid on May 3.  Full Article

Shenzhen Salubris Pharmaceuticals issues 2016 H1 net profit outlook
Monday, 18 Apr 2016 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:Sees net profit for 2016 H1 to increase by 10 percent to 20 percent, or to be 680,986,100 yuan to 742,894,000 yuan.Says the net profit of 2015 H1 was 619,078,300 yuan.Comments that sales increase is the main reason for the forecast.  Full Article

Shenzhen Salubris Pharmaceuticals announces strategic cooperation with Sichuan University
Wednesday, 23 Mar 2016 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:Announced strategic cooperation with Sichuan University.Says to cooperate on innovative drugs.  Full Article

Shenzhen Salubris Pharmaceuticals announces 2015 dividend payment
Monday, 21 Mar 2016 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:To (use undistributed profits to) pay cash dividend of 6 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

Shenzhen Salubris Pharmaceuticals to inject capital in subsidiary
Wednesday, 2 Dec 2015 07:00pm EST 

Shenzhen Salubris Pharmaceuticals Co Ltd:To inject capital of 37.15 mln yuan in its Chengdu-based 80 pct owned biotechnology subsidiary.To raise stake in the subsidiary to 90 pct from 80 pct.  Full Article

Shenzhen Salubris Pharmaceuticals subsidiary announces stake acquisition and capital injection in Shenzhen-based company
Wednesday, 25 Nov 2015 07:00pm EST 

Shenzhen Salubris Pharmaceuticals Co Ltd:Says its Shenzhen-based pharmacy subsidiary to acquire a 60 pct stake in a Shenzhen-based biomedical technology company (target company) at price of 15 mln yuan.Subsidiary to inject capital of 12 mln yuan to the target company after the stake acquisition.Subsidiary to raise stake in the target company to 72.97 pct from 0 pct after all the transactions.  Full Article

Shenzhen Salubris Pharmaceuticals gives 2015 net profit outlook in line with I/B/E/S estimates
Sunday, 25 Oct 2015 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:Sees net profit for 2015 to increase 10 pct to 30 pct, or to be 1,146,526,800 yuan to 1,354,986,200 yuan.The net profit of 2014 was 1,042,297,100 yuan.2015 reported net profit of 1,330.44 mln yuan – Thomson Reuters I/B/E/S.Comments that increased sales income as the main reason for the forecast.  Full Article

Shenzhen Salubris Pharmaceuticals invests in Suzhou-based company
Tuesday, 15 Sep 2015 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:Invested 150 mln yuan in a 24.06 pct owned Suzhou-based biotechnology company.Holds 58.60 pct stake in the Suzhou-based biotechnology company after investment.  Full Article

Shenzhen Salubris Pharmaceuticals to participate in establishment of insurance company
Friday, 24 Apr 2015 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:To invest up to 200 mln yuan to participate in establishment of insurance company.The issuance company with registered capital of 1,050 mln yuan.  Full Article

Shenzhen Salubris Pharmaceuticals announces 2014 dividend payment date
Thursday, 16 Apr 2015 08:00pm EDT 

Shenzhen Salubris Pharmaceuticals Co Ltd:To pay a cash dividend of 7 yuan (before tax) per 10 shares and use additional paid-in capital to distribute 6 new share for every 10 shares, to shareholders of record on April 23 for 2014.The company's shares will be traded ex-right and ex-dividend on April 24 and the dividend will be paid on April 24.  Full Article